Baseline Assessment

Test your baseline knowledge of CRSwNP management. Explore clinical scenarios that assess your approach to identifying biologic candidates, sequencing surgery and biologics, and coordinating care with allergy/immunology.
Anju T. Peters, MD, MSCI, FAAAAI

Associate Chief  
Clinical Research and Practice Innovation
Division of Allergy/Immunology
Northwestern University Feinberg School of Medicine 
Chicago, IL

Anju T. Peters, MD, MS is a Professor in the Department of Medicine and Department of Otolaryngology Head & Neck Surgery. She graduated from University of Michigan Medical School and completed her residency and fellowship in the Division of Allergy-Immunology at Northwestern University Feinberg School of Medicine. She currently serves as the Director of Clinical Research in the Division of Allergy-Immunology at Northwestern University Feinberg School of Medicine. She is also the Medical Director of the Northwestern Medicine Clinical Research Unit.

Cecelia Damask, DO, FAOCOHNS, FAAOA

Clinical Assistant Professor  
Department of Otolaryngology 
University of Central Florida College of Medicine 
Orlando, FL

Dr. Cecelia Damask, DO, FAOCOHNS, FAAOA, is a comprehensive otolaryngologist, with a specialty focus on Allergy and Sinus Diseases, and Assistant Professor in the Department of Otolaryngology at the University of Central Florida College of Medicine. She has extensive training in the treatment of allergies and is an expert in the use of biologics for the treatment of allergic disorders. Dr. Damask is passionate about providing her patients with the highest quality care and is committed to using the latest evidence-based treatments to help her patients achieve optimal health. 

1.
UTILIZE clinical and inflammatory features that guide biologic selection and signal recurrence risk in CRSwNP
2.
DETERMINE how and when to incorporate biologics into CRSwNP management and sequencing treatment before, after, or in place of FESS
3.
IMPLEMENT treatment strategies that incorporate biologics as add-on maintenance therapy for type 2 inflammation in CRSwNP, based on emerging guidance
4.
STRENGTHEN cross-specialty collaboration between ENTs and allergists to ensure timely, coordinated care and appropriate integration of biologic therapies in CRSwNP